Drug Shortage Report for ZERIT - CAP 20MG
Report ID | 55662 |
Drug Identification Number | 02216094 |
Brand name | ZERIT - CAP 20MG |
Common or Proper name | STAVUDINE |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | STAVUDINE |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 1 BTL x 60 |
ATC code | J05AF |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-03-25 |
Actual start date | |
Estimated end date | 2019-03-25 |
Actual end date | 2019-03-28 |
Shortage status | Resolved |
Updated date | 2019-03-29 |
Company comments | Product on allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-07-13 | English | Compare |
v2 | 2018-07-13 | French | Compare |
v3 | 2018-08-17 | English | Compare |
v4 | 2018-08-17 | French | Compare |
v5 | 2018-10-09 | English | Compare |
v6 | 2018-10-09 | English | Compare |
v7 | 2018-10-09 | French | Compare |
v8 | 2018-11-15 | English | Compare |
v9 | 2018-11-15 | French | Compare |
v10 | 2018-12-06 | English | Compare |
v11 | 2018-12-06 | English | Compare |
v12 | 2018-12-06 | French | Compare |
v13 | 2019-01-01 | English | Compare |
v14 | 2019-01-01 | English | Compare |
v15 | 2019-01-01 | French | Compare |
v16 | 2019-01-09 | English | Compare |
v17 | 2019-01-09 | English | Compare |
v18 | 2019-01-09 | French | Compare |
v19 | 2019-01-11 | English | Compare |
v20 | 2019-01-11 | French | Compare |